link
- NIH is enrolling patients in an early stage clinical trial to test a universal flu vaccine based on mRNA technology.
- The technology is behind Moderna’s and Pfizer’s widely used Covid vaccines.
- Scientists hope the vaccine will protect against a wide variety of flu strains and provide long-term immunity so people do not have to receive a shot every year.
Fool me once… ABN